Shanghai Fudan Forward S&T Co (600624) Fair Value & Analysis
Industrials · CN · Market cap 2.7B CNY
Fair value as of: Jul 25, 2026
From 4 valuation models · updated today
Share price −7.2% over the past month.
Price vs Fair Value (12 months)
12‑month range ¥3.35 – ¥7.53 · fair‑value band ¥0.1800 – ¥0.5700 · the ¥3.48 price screens above the ¥0.3400 fair value. As of Jul 25, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Shanghai Fudan Forward S&T Co (600624) currently trades at ¥3.48, while our model-based Fair Value estimate is ¥0.3400, implying the stock looks roughly 90.2% overvalued today. We read business quality at 36/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Over the trailing twelve months, Shanghai Fudan Forward S&T Co generated revenue of 640M CNY at a net margin of -30.9%. Revenue declined 7.3% year over year. It earns a return on equity of -35.0%. Net debt stands at 301M CNY. Fundamentals as of Jul 25, 2026
Our scenario range runs from ¥0.1800 (bear case) to ¥0.5700 (bull case); at ¥3.48, the current price sits above that range. The share trades about 56% below its 52-week high, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -27% fair-value upside, at -90%, 600624 screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 25, 2026. TTM = trailing twelve months.
About the company
Shanghai Fudan Forward S&T Co., Ltd engages in the medical and health, digital economy, high-tech, and other businesses. The company is involved in the research and development, production, and sales of computer systems, communication equipment, automation instruments, biotechnology, light source lighting, and other products; and import and export business. It also engages in the research and development, production, and sales of chemical raw materials, chemical pharmaceutical preparations, and traditional Chinese medicine; exporting software to Japan in the fintech sector; and development, construction, operation, and management of high-tech parks. In addition, the company provides investment and consulting services in the high-tech field; distributes car audio and high-end car care products; processes sheet metals; and develops health management systems. Further, it focuses on specialized drugs and specialty drugs; and digestive system drugs, nervous system drugs, anti-tumor …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Shanghai Fudan Forward S&T Co reported revenue of ¥640M in FY2025 versus ¥1.0B in FY2021, a compound −11.5%/yr. Reported net income was −¥198M in FY2025.
Is 600624 fairly valued? → Check now
Similar stocks
10 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Jul 25, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Honeywell International Inc HON | 3,736 MXN | 111.48 MXN | -97% |
| CITIC Limited 0267 | HK$12.30 | HK$37.22 | +203% |
| Swire Pacific Limited 0019 | HK$81.70 | HK$13.77 | -83% |
| SK Inc 034730 | 579,000 KRW | 370,641 KRW | -36% |
| PT Astra International Tbk, ASII | 4,360 IDR | 12,700 IDR | +191% |
| Grupo Carso, S.A. GCARSOA1 | 130.55 MXN | 103.68 MXN | -21% |
| The Siam Cement Public Company SCC | 233.00 THB | 169.42 THB | -27% |
| SRF Limited SRF | ₹2,737 | ₹1,053 | -62% |
| Empresas Copec S.A COPEC | 5,967 CLP | 13.86 CLP | -100% |
| Posco International Corporation 047050 | 58,300 KRW | 56,299 KRW | -3% |
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Shanghai Fudan Forward S&T Co (600624) undervalued?
What is the fair value of 600624?
What is the quality score of 600624?
What is the revenue of Shanghai Fudan Forward S&T Co (600624)?
What is the net profit margin of 600624?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Shanghai Fudan Forward S&T Co analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.